(Q44944679)

7 December 2017

A proposed scoring system for predicting mortality in melioidosis (English)

1 reference

7 December 2017

0 references

1

1 reference

7 December 2017

3

Nicholas M Anstey

1 reference

7 December 2017

4

Bart J Currie

1 reference

7 December 2017

Susan P Jacups

2

1 reference

7 December 2017

1 September 2003

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

7 December 2017

1 reference

7 December 2017

97

1 reference

7 December 2017

5

1 reference

7 December 2017

577-581

1 reference

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2980035-4

7 January 2021

Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2980035-4

7 January 2021

Melioidosis: acute and chronic disease, relapse and re-activation

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2980035-4

7 January 2021

Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2980035-4

7 January 2021

Melioidosis: the tip of the iceberg?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2980035-4

7 January 2021

Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2980035-4

7 January 2021

Comparison of multiple organ dysfunction scores in the prediction of hospital mortality in the critically ill

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2980035-4

7 January 2021

Peripheral blood lymphocyte subsets in acute human melioidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2980035-4

7 January 2021

Early goal-directed therapy in the treatment of severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2980035-4

7 January 2021

Comparison of imipenem and ceftazidime as therapy for severe melioidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2980035-4

7 January 2021

Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2980035-4

7 January 2021

The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2980035-4

7 January 2021

Prognostic significance of quantitative bacteremia in septicemic melioidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2980035-4

7 January 2021

Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2980035-4

7 January 2021

10.1016/S0035-9203(03)80035-4

Identifiers

DOI

1 reference

7 December 2017

1 reference

PubMed ID

15307431